This $254,153 Project Grant awarded by the Defense Health Agency on March 1, 2025 supports research on microplastics and prostate cancer conducted by New York University School of Medicine. The funding is provided through the Military Medical Research and Development program (CFDA 12.420), which supports a wide range of biomedical research initiatives to improve health outcomes for military personnel, veterans, and the general public. The project at NYU School of Medicine will explore the potential links between exposure to microplastics and the development of prostate cancer, with the goal of advancing scientific understanding and informing future prevention and treatment strategies. This award represents one of the diverse research projects funded under the Military Medical Research and Development program, which covers critical areas like cancer, neurological disorders, and emerging medical technologies. The performance period for this grant is from March 1, 2025 to February 28, 2027.
Generated 3/4/25, 6:49 AM